Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
Public ClinicalTrials.gov record NCT00507936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global, Multicenter, Randomized, Double-Blind Placebo Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects With Diabetic Neuropathic Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the efficacy and the safety of ABT-894 (1mg, 2mg or 4mg capsules) administered BID to placebo in the treatment of DNP. Another treatment arm will be Duloxetine 60mg administered once daily (QD). Approximately 275 subjects will be enrolled into the study at approximately 50 sites in both the United States and Europe. The study will be divided into the following periods: Screening/Washout (21 days) followed by a Baseline Visit, an 8-week Treatment Period and a 1-week Follow-up Visit.
Study identification
- NCT ID
- NCT00507936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2007 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- Jan 23, 2013
2007 – 2008
United States locations
- U.S. sites
- 29
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 5207 | Mesa | Arizona | 85210 | — |
| Site Reference ID/Investigator# 6053 | Phoenix | Arizona | 85023 | — |
| Site Reference ID/Investigator# 5206 | Little Rock | Arkansas | 72205 | — |
| Site Reference ID/Investigator# 7387 | North Little Rock | Arkansas | 72114 | — |
| Site Reference ID/Investigator# 6052 | Anaheim | California | 92801 | — |
| Site Reference ID/Investigator# 7064 | Garden Grove | California | 92845 | — |
| Site Reference ID/Investigator# 8286 | National City | California | 91950 | — |
| Site Reference ID/Investigator# 5276 | Clearwater | Florida | 33765 | — |
| Site Reference ID/Investigator# 6781 | Hialeah | Florida | 33012 | — |
| Site Reference ID/Investigator# 7514 | Palm Beach Gardens | Florida | 33418 | — |
| Site Reference ID/Investigator# 8113 | Tampa | Florida | 33603 | — |
| Site Reference ID/Investigator# 6047 | Pasadena | Maryland | 21122 | — |
| Site Reference ID/Investigator# 5277 | Brockton | Massachusetts | 02301 | — |
| Site Reference ID/Investigator# 6043 | St Louis | Missouri | 63117 | — |
| Site Reference ID/Investigator# 6044 | St Louis | Missouri | 63141 | — |
| Site Reference ID/Investigator# 7906 | Omaha | Nebraska | 68131 | — |
| Site Reference ID/Investigator# 6045 | New York | New York | 10003 | — |
| Site Reference ID/Investigator# 5946 | New York | New York | 10022 | — |
| Site Reference ID/Investigator# 5216 | New York | New York | 10065 | — |
| Site Reference ID/Investigator# 7483 | New York | New York | 10128 | — |
| Site Reference ID/Investigator# 5947 | Cincinnati | Ohio | 45245 | — |
| Site Reference ID/Investigator# 6869 | Cuyahoga Falls | Ohio | 44223 | — |
| Site Reference ID/Investigator# 5217 | Portland | Oregon | 97239 | — |
| Site Reference ID/Investigator# 7699 | Houston | Texas | 77074 | — |
| Site Reference ID/Investigator# 5836 | San Antonio | Texas | 78218 | — |
| Site Reference ID/Investigator# 5899 | San Antonio | Texas | 78229-4801 | — |
| Site Reference ID/Investigator# 5950 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 7187 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 6054 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00507936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2013 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00507936 live on ClinicalTrials.gov.